Long-Term Investment

6 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

LONG-TERM INVESTMENT

Note 8 – LONG-TERM INVESTMENT

Long-term investment consists of the following:

	September 30, 2020			March 31, 2020
Kahamadi Bio (1)	$	175	*	$	6,217	*
Zhetong Medical (2)		4,115,664			2,538,234
Long-term investment	$	4,115,839		$	2,544,451

(1) It represents 49% investment in Kahamadi Bio. The investment is recorded using the equity method. Kahamadi Bio suffered loss of $6,127 in the six months ended September 30, 2020.

(2) It represents 39% investment in Zhejiang Zhetong Medical Co., Ltd. ("Zhetong Medical"). Zhetong Medical was established in March 2020 to target potential acquisitions or cooperate with local pharmacies. By attracting more funds from local investors, the Company expects to continue growing its local network in the future. In the six months ended September 30, 2020, Jiuzhou Pharmacy injected funds of approximately $1,577,430 into Zhetong Medical. The investment is recorded based on equity method.